EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 17 filers reported holding EYEGATE PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $3,000 | -25.0% | 14,553 | 0.0% | 0.00% | – |
Q1 2019 | $4,000 | -42.9% | 14,553 | 0.0% | 0.00% | – |
Q4 2018 | $7,000 | +40.0% | 14,553 | 0.0% | 0.00% | – |
Q3 2018 | $5,000 | -37.5% | 14,553 | 0.0% | 0.00% | – |
Q2 2018 | $8,000 | +33.3% | 14,553 | 0.0% | 0.00% | – |
Q1 2018 | $6,000 | -62.5% | 14,553 | 0.0% | 0.00% | – |
Q4 2017 | $16,000 | +23.1% | 14,553 | +29.1% | 0.00% | – |
Q3 2017 | $13,000 | – | 11,277 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 1,616,000 | $1,891,000 | 0.22% |
SABBY MANAGEMENT, LLC | 46,378 | $54,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 32,022 | $37,000 | 0.00% |
Vantage Investment Advisors, LLC | 6,500 | $8,000 | 0.00% |
IFP Advisors, Inc | 25,800 | $30,000 | 0.00% |
Virtu Financial LLC | 15,967 | $19,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 524 | $1,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 100 | $0 | 0.00% |
NORTHERN TRUST CORP | 11,277 | $13,000 | 0.00% |
CREDIT SUISSE AG/ | 30,000 | $35,000 | 0.00% |